{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T14:34:35Z","timestamp":1772807675657,"version":"3.50.1"},"reference-count":50,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2016,1,19]],"date-time":"2016-01-19T00:00:00Z","timestamp":1453161600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0147260","type":"journal-article","created":{"date-parts":[[2016,1,19]],"date-time":"2016-01-19T20:29:51Z","timestamp":1453235391000},"page":"e0147260","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":6,"title":["Oral Administration of Silkworm-Produced GAD65 and Insulin Bi-Autoantigens against Type 1 Diabetes"],"prefix":"10.1371","volume":"11","author":[{"given":"Baoping","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Yue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongfeng","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2016,1,19]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1600-065X.2011.01017.x","article-title":"Oral tolerance","volume":"241","author":"HL Weiner","year":"2011","journal-title":"Immunol Rev"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.addr.2012.10.013","article-title":"Mechanism of oral tolerance induction to therapeutic proteins","volume":"65","author":"XM Wang","year":"2013","journal-title":"Adv Drug Delivery Rev"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1038\/414792a","article-title":"beta-cell death during progression to diabetes","volume":"414","author":"D Mathis","year":"2001","journal-title":"Nature"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"95fs1","DOI":"10.1126\/scitranslmed.3002981","article-title":"Type 1 diabetes immunotherapy: is the glass half empty or half full?","volume":"3","author":"KC Herold","year":"2011","journal-title":"Sci Transl Med"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/nri3422","article-title":"Type 1 diabetes: translating mechanistic observations into effective clinical outcomes","volume":"13","author":"KC Herold","year":"2013","journal-title":"Nature Rev Immunol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1126\/science.6362005","article-title":"Insulin antibodies in insulin-dependent diabetics before insulin treatment","volume":"222","author":"JP Palmer","year":"1983","journal-title":"Science"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1146\/annurev.iy.08.040190.003243","article-title":"Type-I diabetes-a chronic autoimmune-disease of human, mouse, and rat","volume":"8","author":"L Castano","year":"1990","journal-title":"Ann Rev Immunol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/366069a0","article-title":"Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes","volume":"366","author":"DL Kaufman","year":"1993","journal-title":"Nature"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/nm0797-793","article-title":"Transgenic plants expressing autoantigens fed to mice to induce oral immune tolerance","volume":"3","author":"SW Ma","year":"1997","journal-title":"Nature Med"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1038\/nbt1098-934","article-title":"A plant-based cholera toxin B subunit-insulin fusion protein protects against the development of autoimmune diabetes","volume":"16","author":"T Arakawa","year":"1998","journal-title":"Nature Biotechnol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.2337\/diabetes.48.11.2150","article-title":"Oral administration of cholera toxin B-insulin conjugates protects NOD mice from autoimmune diabetes by inducing CD4(+) regulatory T-cells","volume":"48","author":"C Ploix","year":"1999","journal-title":"Diabetes"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1016\/j.vaccine.2006.10.039","article-title":"Suppression of diabetes in non-obese diabetic (NOD) mice by oral administration of a cholera toxin B subunit-insulin B chain fusion protein vaccine produced in silkworm","volume":"25","author":"Z Gong","year":"2007","journal-title":"Vaccine"},{"key":"ref13","first-page":"831704","article-title":"Protection against autoimmune diabetes by silkworm-produced GFP-tagged CTB-insulin fusion protein","author":"Q Meng","year":"2011","journal-title":"Clin Dev Immunol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.2337\/db13-1236","article-title":"Oral delivery of glutamic acid decarboxylase (GAD)-65 and IL-10 by <italic>Lactococcus lactis<\/italic> reverses diabetes in recent-onset NOD mice","volume":"63","author":"S Robert","year":"2014","journal-title":"Diabetes"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jaut.2013.05.002","article-title":"The clinical and immunological significance of GAD-specific autoantibody and T-cell responses in type 1 diabetes","volume":"44","author":"T Boettler","year":"2013","journal-title":"J Autoimmun"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1007\/s001250051482","article-title":"No effect of oral insulin on residual beta-cell function in resent-onset Type I diabetes (the IMDIAB VII)","volume":"43","author":"P Pozzilli","year":"2000","journal-title":"Diabetologia"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S0140-6736(00)02579-4","article-title":"Oral insulin administration and residual beta-cell function in recent-onset type 1 diabetes: a multicentre randomised controlled trial","volume":"356","author":"L Chaillous","year":"2000","journal-title":"Lancet"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.2337\/db11-1304","article-title":"Preexisting autoantibodies predict efficacy of oral insulin to cure autoimmune diabetes in combination with Anti-CD3","volume":"61","author":"AA Mamchak","year":"2012","journal-title":"Diabetes"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.2337\/diacare.28.5.1068","article-title":"Effects of oral insulin in relatives of patients with type 1 diabetes\u2014The diabetes prevention trial-type 1","volume":"28","author":"JS Skyler","year":"2005","journal-title":"Diabetes Care"},{"key":"ref20","first-page":"14","article-title":"Type 1 Diabetes TrialNet-An International Collaborative Clinical Trials Network","volume":"1150","author":"JS Skyler","year":"2008","journal-title":"Immunol Diabetes"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"5680","DOI":"10.1073\/pnas.0307420101","article-title":"Induction of oral tolerance to prevent diabetes with transgenic plants requires glutamic acid decarboxylase (GAD) and IL-4","volume":"101","author":"SW Ma","year":"2004","journal-title":"Proc. Natl Acad Sci USA"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1046\/j.1365-3083.2003.01248.x","article-title":"The cholera toxin B subunit is a mucosal adjuvant for oral tolerance induction in type 1 diabetes","volume":"57","author":"S Bregenholt","year":"2003","journal-title":"Scand J Immunol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"4052","DOI":"10.1016\/j.vaccine.2010.04.005","article-title":"Glutamic acid decarboxylase epitope protects against autoimmune diabetes through activation of Th2 immune response and induction of possible regulatory mechanism","volume":"28","author":"ZH Gong","year":"2010","journal-title":"Vaccine"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"4610","DOI":"10.1073\/pnas.94.9.4610","article-title":"A cholera toxoid-insulin conjugate as an oral vaccine against spontaneous autoimmune diabetes","volume":"94","author":"I Bergerot","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3109\/08916939708994736","article-title":"Effect of oral and intravenous insulin and glutamic acid decarboxylase in NOD mice","volume":"26","author":"VK Ramiya","year":"1997","journal-title":"Autoimmunity"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0168-1656(02)00060-3","article-title":"Enzymatic characterization of a recombinant isoform hybrid of glutamic acid decarboxylase (rGAD67\/65) expressed in yeast","volume":"97","author":"JC Tong","year":"2002","journal-title":"J biotechnol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/lam.12188","article-title":"J, Kim HJ. Oral immunization with whole yeast producing viral capsid antigen provokes a stronger humoral immune response than purified viral capsid antigen","volume":"58","author":"HJ Kim","year":"2014","journal-title":"Lett Appl Microbiol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"10986","DOI":"10.1073\/pnas.0703766104","article-title":"Rice-based mucosal vaccine as a global strategy for cold-chain- and needle-free vaccination","volume":"104","author":"T Nochi","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s00299-005-0069-2","article-title":"Expression of cholera toxin B subunit and the B chain of human insulin as a fusion protein in transgenic tobacco plants","volume":"25","author":"D Li","year":"2006","journal-title":"Plant Cell Rep"},{"key":"ref30","first-page":"580463","article-title":"Expression systems and species used for transgenic animal bioreactors","author":"YL Wang","year":"2013","journal-title":"Biomed Res Int"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.fct.2006.01.009","article-title":"Safety evaluation of protein of silkworm (<italic>Antheraea pernyi<\/italic>) pupae","volume":"44","author":"J Zhou","year":"2006","journal-title":"Food Chem Toxicol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s11248-014-9826-8","article-title":"The advances and perspectives of recombinant protein production in the silk gland of silkworm <italic>Bombyx mori<\/italic>","volume":"23","author":"HF Xu","year":"2014","journal-title":"Transgenic Res"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jbiotec.2005.05.027","article-title":"Oral administration of a cholera toxin B subunit-insulin fusion protein produced in silkworm protects against autoimmune diabetes","volume":"119","author":"Z Gong","year":"2005","journal-title":"J biotechnol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"e5353","DOI":"10.1371\/journal.pone.0005353","article-title":"Bioavailability of Orally Administered rhGM-CSF: A single-dose, randomized, open-label, two-period crossover trial","volume":"4","author":"WP Zhang","year":"2009","journal-title":"Plos One"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/978-1-4615-4729-7_14","article-title":"Autoantigens produced in plants for oral tolerance therapy of autoimmune diseases","volume":"464","author":"SW Ma","year":"1999","journal-title":"Adv. Exp.Med.Biol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/nature03523","article-title":"Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice","volume":"435","author":"M Nakayama","year":"2005","journal-title":"Nature"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"211ra156","DOI":"10.1126\/scitranslmed.3006534","article-title":"Restoration of the unfolded protein response in pancreatic beta cells protects mice against type 1 diabetes","volume":"5","author":"F Engin","year":"2013","journal-title":"Sci Transl Med"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"a007773","DOI":"10.1101\/cshperspect.a007773","article-title":"Antigen-specific therapeutic approaches in type 1 diabetes","volume":"2","author":"X Clemente-Casares","year":"2012","journal-title":"Cold Spring Harb Perspect Med"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1084\/jem.20030215","article-title":"Normal incidence of diabetes in NOD mice tolerant to glutamic acid decarboxylase","volume":"197","author":"E Jaeckel","year":"2003","journal-title":"J Exp Med"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1006\/clim.2002.5298","article-title":"During the early prediabetic period in NOD mice, the pathogenic CD8(+) T-cell population comprises multiple antigenic specificities","volume":"105","author":"TP Dilorenzo","year":"2002","journal-title":"Clin Immunol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S1074-7613(04)00111-6","article-title":"Back to central tolerance","volume":"20","author":"D Mathis","year":"2004","journal-title":"Immunity"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/ni.1844","article-title":"Chromogranin A is an autoantigen in type 1 diabetes","volume":"11","author":"BD Stadinski","year":"2010","journal-title":"Nature Immunol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.ijcard.2014.06.001","article-title":"Oral dosing with multi-antigenic construct induces atheroprotective immune tolerance to individual peptides in mice","volume":"175","author":"L Mundkur","year":"2014","journal-title":"Int J Cardiol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"894","DOI":"10.2337\/diabetes.47.6.894","article-title":"Induction of GAD65-specific regulatory T-cells inhibits ongoing autoimmune diabetes in nonobese diabetic mice","volume":"47","author":"R Tisch","year":"1998","journal-title":"Diabetes"},{"key":"ref45","first-page":"223","article-title":"Th1\/Th2 balance: the hypothesis, its limitations, and implications for health and disease","volume":"8","author":"P Kidd","year":"2003","journal-title":"J clin therapeutic"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1046\/j.1365-2249.2002.01988.x","article-title":"Nasal administration of CTB-insulin induces active tolerance against autoimmune diabetes in non-obese diabetic (NOD) mice","volume":"130","author":"C Aspord","year":"2002","journal-title":"Clin Exp Immunol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1007\/s00018-008-7496-5","article-title":"Cholera toxin structure, gene regulation and pathophysiological and immunological aspects","volume":"65","author":"J Sanchez","year":"2008","journal-title":"Cell Mol Life Sci"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1097\/01.cji.0000171315.82997.9a","article-title":"Protection of NOD mice from type 1 diabetes after oral inoculation with vaccinia viruses expressing adjuvanted islet autoantigens","volume":"28","author":"B Denes","year":"2005","journal-title":"J Immunother"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s12026-011-8215-0","article-title":"A multivalent vaccine for type 1 diabetes skews T cell subsets to Th2 phenotype in NOD mice","volume":"50","author":"MS Lin","year":"2011","journal-title":"Immunol Res"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1111\/j.1467-7652.2010.00507.x","article-title":"Plant-made vaccines for humans and animals","volume":"8","author":"EP Rybicki","year":"2010","journal-title":"Plant Biotechnol J"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0147260","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,24]],"date-time":"2018-10-24T02:50:30Z","timestamp":1540349430000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0147260"}},"subtitle":[],"editor":[{"given":"Marc S","family":"Horwitz","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2016,1,19]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,1,19]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0147260","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,19]]}}}